NutraSift: The nutraceutical innovation podcast

Andrographis: The 'King of Bitters' that Thailand used as a COVID treatment

5 min · 22. touko 2026
jakson Andrographis: The 'King of Bitters' that Thailand used as a COVID treatment kansikuva

Kuvaus

In 2021, Thailand's Department of Thai Traditional and Alternative Medicine approved andrographis (Fah Talai Jone) for early-stage COVID-19 treatment. Andrographolide covalently binds to the p50 subunit of NF-kB one of the most specific and irreversible anti-inflammatory mechanisms known in natural products. This isn't weak binding or allosteric modulation. It's a covalent modification. That's drug-level mechanism specificity in a plant extract that costs pennies. Publications of interest: https://pubmed.ncbi.nlm.nih.gov/15356172/ https://pmc.ncbi.nlm.nih.gov/articles/PMC11246112/ https://pmc.ncbi.nlm.nih.gov/articles/PMC12351123/

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity NutraSift: The nutraceutical innovation podcast-yhteisöön!

Aloita maksutta

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi. · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

72 jaksot

jakson Can we actually reverse aging? Scientists just put it to the test in humans. kansikuva

Can we actually reverse aging? Scientists just put it to the test in humans.

This week, the first patient was dosed in a landmark trial of ER-100, the first cellular reprogramming therapy to reach people. We unpack the science behind "making cells young again": how three Yamanaka transcription factors reset the epigenetic clock without touching your DNA, why dropping the cancer-linked one matters, and the clever doxycycline "off-switch" that makes it safe enough for the clinic. Then the practical aspects. Gene therapy is reversal in the clinic, but what about the rest population? We dig into where natural bioactives fit for everyday prevention, why ingredient synergy beats single molecules, and how AI is bringing personalized formulations to longevity. Publications of interest: World-first: therapy to make cells young again trialled in a person [https://www.nature.com/articles/d41586-026-01836-7]  https://www.lifebiosciences.com/life-biosciences-announces-first-patient-dosed-in-phase-1-trial-of-er-100-for-optic-neuropathies/ [https://]  https://clinicaltrials.gov/study/NCT07290244 [https://]  https://www.technologynetworks.com/biopharma/articles/re-setting-the-epigenetic-clock-to-reverse-cellular-aging-413392

10. kesä 20268 min